Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Steven G. Avey"'
Publikováno v:
Journal of Anaesthesiology Clinical Pharmacology, Vol 32, Iss 4, Pp 440-445 (2016)
Statins are a mainstay of hyperlipidemia treatment. These drugs inhibit the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase and have beneficial effects on atherosclerosis including plaque stabilization, reduction of platelet activation, and re
Externí odkaz:
https://doaj.org/article/b4d6a6bec773400cab39ac3d6c62caff
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 26:798-816
OBJECTIVE: To review the literature on the subject of quality improvement principles and methods applied to pharmacy services and to describe a framework for current and future efforts in pharmacy ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d44a9e936d2c9245da9fcc6999bfaf2d
https://doi.org/10.18553/jmcp.2020.26.7.798
https://doi.org/10.18553/jmcp.2020.26.7.798
Autor:
Elizabeth Sampsel, D. S. 'Pete' Fullerton, John B. Watkins, Steven G. Avey, Richard N. Fry, Jennifer S. Graff, Sean D. Sullivan, Jeff Lee, Iris M. Tam
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 26:696-700
DISCLOSURES: No funding was required for this project. The authors are or have been members of the Format Executive Committee.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf42d21df220fae24a5630c2aa06c1c
https://doi.org/10.18553/jmcp.2020.26.6.696
https://doi.org/10.18553/jmcp.2020.26.6.696
Autor:
Steven G. Avey
Publikováno v:
Journal of managed carespecialty pharmacy. 26(4)
No funding was received for the writing of this reflection. Avey is a member of the AMCP Foundation and has recently retired from MedImpact Health Systems, where he served as Vice President of Specialty Clinical Solutions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4757e1fb56605e4d0a5cdc63dfd333b3
https://pubmed.ncbi.nlm.nih.gov/32223598
https://pubmed.ncbi.nlm.nih.gov/32223598
Publikováno v:
Journal of Anaesthesiology, Clinical Pharmacology
Journal of Anaesthesiology Clinical Pharmacology, Vol 32, Iss 4, Pp 440-445 (2016)
Journal of Anaesthesiology Clinical Pharmacology, Vol 32, Iss 4, Pp 440-445 (2016)
Statins are a mainstay of hyperlipidemia treatment. These drugs inhibit the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase and have beneficial effects on atherosclerosis including plaque stabilization, reduction of platelet activation, and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aef225f0284eed7fdf81c3d9cb68d54
https://pubmed.ncbi.nlm.nih.gov/28096572
https://pubmed.ncbi.nlm.nih.gov/28096572
Publikováno v:
Journal of Managed Care Pharmacy. 11:1-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3102c7f968f1247de168ecae460820d
https://doi.org/10.18553/jmcp.2005.11.3.1
https://doi.org/10.18553/jmcp.2005.11.3.1
Publikováno v:
Journal of Managed Care Pharmacy. 11:1-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb0df3e7be49adde09c90f0f767d31c1
https://doi.org/10.18553/jmcp.2005.11.2.1
https://doi.org/10.18553/jmcp.2005.11.2.1
Publikováno v:
Value in Health. 6(5):505-521
Objective The objective of this report is to provide, in detail, the evidentiary requirements contained in Version 2.0 of the Academy of Managed Care Pharmacy's (AMCP's) Format for Formulary Submissions and to elaborate on several key issues regardin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97453e8fe320b363150d61fefe732e71
Autor:
Steven G. Avey
Publikováno v:
Journal of managed care pharmacy : JMCP. 11
OBJECTIVE: To describe AMCP's Framework for Quality Drug Therapy. SUMMARY: AMCP's Framework for Quality Drug Therapy was designed by a consortium of pharmacists and pharmacy organizations. It was built on customer assumptions and expectations, and it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93188396ed1243726848fa3931cf76e5
https://pubmed.ncbi.nlm.nih.gov/23577427
https://pubmed.ncbi.nlm.nih.gov/23577427
Autor:
Diana I, Brixner, Vijay N, Joish, Gary M, Odera, Steven G, Avey, Douglas M, Hanson, H Eric, Cannon
Publikováno v:
The American journal of managed care. 13(6 Pt 2)
To assess the effects of benefit design change (BDC) on medication adherence and persistence (including switch in therapy), drug costs, and total healthcare costs.A retrospective study was performed using administrative claims data from an integrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87bb87a946770abf0d0792c73c8abe71
https://pubmed.ncbi.nlm.nih.gov/17567238
https://pubmed.ncbi.nlm.nih.gov/17567238